TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/24 16:20 | 3/4/24 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | O | COO | M.d | 152 | 10.15 | 0 | 15 | 63 | 39 | D | ||||||||||||||
3/6/24 16:20 | 3/4/24 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | O | COO | S.d | -814 | 19.76 | 0 | -41 | -51 | 39 | D | ||||||||||||||
2/20/24 18:04 | 2/15/24 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | O | COO | M.d | 0 | 0.00 | 0 | 17 | 34 | 65 | D | ||||||||||||||
10/31/22 16:36 | 10/28/22 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | O | COO | M.d | 13 | 1.51 | 0 | 9 | 19 | 53 | D | ||||||||||||||
3/4/22 17:45 | 3/4/22 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | O | COO | M.d | 0 | 0.9400 | 0 | 1 | 1 | 45 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |